BARDA Awards $30M toward NewLink-Merck Ebola Vaccine Candidate

Grant intended to support manufacturing and development for rVSV-EBOV, including a new 330-person Phase Ib study
Hand in hand climbing up

Customer Insights: Roivant Scales up Bioprocesses through a CDMO

Sponsored Content Brought to you by Having been in the industry for more than 25 years, Patrick Guertin knows that cells can be temperamental and don’t like to be rushed, but in today’s biopharma industry speed to...

CMC Biologics to Manufacture ProtAffin’s Preclinical-Stage IL-8 Decoy

Glycan-binding anti-inflammatory protein designed to block activation of neutrophils.

Transgene and Vivalis to Evaluate MVA Vaccine Production in EB66 Duck Stem Cell Line

Firm is looking for alternative platform to CEF manufacture for clinical-stage cancer and infectious disease vaccines.

Orgenesis Acquires MaSTherCell

Buyer says deal will speed up development of lead product, AIPCs for type 1 diabetes, from pre-clinical testing into clinical trials

Samsung Biologics, BMS in Manufacturing Partnership

Samsung Biologics and Bristol-Myers Squibb have entered into a 10-year agreement under which Samsung will manufacture an antibody cancer drug for BMS.
Firm will now be able to offer sterile fill and finish services for small molecules and biologics. [© Thomas Brugger -]

AMRI Takes Over Hyaluron for $27M

Firm will now be able to offer sterile fill and finish services for small molecules and biologics.

Rutgers University Cell and DNA Repository Taps PerkinElmer NGS Sample Prep Solutions

Automation is key to facilitating the availability of samples for research.

ExcellGene Extends Supply Agreement for Polyplus-Transfection’s Reagents

PEI transfection reagents are designed to enable protein production in the medium-to-large scale ranges.

CSL Negotiates Option to Pevion’s Candida Vaccine for Australia and New Zealand

Virosome-based vaccine is in early clinical development for treating chronic recurrent thrush.

Recently Featured

Stay Connected

Scroll Up